Victoria Ng1, Aamir Fazil2, Lisa A Waddell2, Christina Bancej2, Patricia Turgeon2, Ainsley Otten2, Nicole Atchessi2, Nicholas H Ogden2. 1. Public Health Risk Sciences Division (Ng, Fazil, Waddell, Turgeon, Otten, Ogden), National Microbiology Laboratory, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Guelph, Ont., and St. Hyacinthe, Que.; Centre for Immunization and Respiratory Infectious Diseases (Bancej), Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Ottawa, Ont.; Office of Biosecurity Programs and Planning (Atchessi), Centre for Biosecurity, Health Security Infrastructure Branch, Public Health Agency of Canada, Ottawa, Ont. victoria.ng@canada.ca. 2. Public Health Risk Sciences Division (Ng, Fazil, Waddell, Turgeon, Otten, Ogden), National Microbiology Laboratory, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Guelph, Ont., and St. Hyacinthe, Que.; Centre for Immunization and Respiratory Infectious Diseases (Bancej), Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Ottawa, Ont.; Office of Biosecurity Programs and Planning (Atchessi), Centre for Biosecurity, Health Security Infrastructure Branch, Public Health Agency of Canada, Ottawa, Ont.
Abstract
BACKGROUND: Continual efforts to eliminate community transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will be needed to prevent additional waves of infection. We explored the impact of nonpharmaceutical interventions on projected SARS-CoV-2 transmission in Canada. METHODS: We developed an age-structured agent-based model of the Canadian population simulating the impact of current and projected levels of public health interventions on SARS-CoV-2 transmission. Interventions included case detection and isolation, contact tracing and quarantine, physical distancing and community closures, evaluated alone and in combination. RESULTS: Without any interventions, 64.6% (95% credible interval [CrI] 63.9%-65.0%) of Canadians will be infected with SARS-CoV-2 (total attack rate) and 3.6% (95% CrI 2.4%-3.8%) of those infected and symptomatic will die. If case detection and contact tracing continued at baseline levels without maintained physical distancing and reimplementation of restrictive measures, this combination brought the total attack rate to 56.1% (95% CrI 0.05%-57.1%), but it dropped to 0.4% (95% CrI 0.03%-23.5%) with enhanced case detection and contact tracing. Combining the latter scenario with maintained physical distancing reduced the total attack rate to 0.2% (95% CrI 0.03%-1.7%) and was the only scenario that consistently kept hospital and intensive care unit bed use under capacity, prevented nearly all deaths and eliminated the epidemic. Extending school closures had minimal effects but did reduce transmission in schools; however, extending closures of workplaces and mixed-age venues markedly reduced attack rates and usually or always eliminated the epidemic under any scenario. INTERPRETATION: Controlling SARS-CoV-2 transmission will depend on enhancing and maintaining interventions at both the community and individual levels. Without such interventions, a resurgent epidemic will occur, with the risk of overwhelming our health care systems.
BACKGROUND: Continual efforts to eliminate community transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will be needed to prevent additional waves of infection. We explored the impact of nonpharmaceutical interventions on projected SARS-CoV-2 transmission in Canada. METHODS: We developed an age-structured agent-based model of the Canadian population simulating the impact of current and projected levels of public health interventions on SARS-CoV-2 transmission. Interventions included case detection and isolation, contact tracing and quarantine, physical distancing and community closures, evaluated alone and in combination. RESULTS: Without any interventions, 64.6% (95% credible interval [CrI] 63.9%-65.0%) of Canadians will be infected with SARS-CoV-2 (total attack rate) and 3.6% (95% CrI 2.4%-3.8%) of those infected and symptomatic will die. If case detection and contact tracing continued at baseline levels without maintained physical distancing and reimplementation of restrictive measures, this combination brought the total attack rate to 56.1% (95% CrI 0.05%-57.1%), but it dropped to 0.4% (95% CrI 0.03%-23.5%) with enhanced case detection and contact tracing. Combining the latter scenario with maintained physical distancing reduced the total attack rate to 0.2% (95% CrI 0.03%-1.7%) and was the only scenario that consistently kept hospital and intensive care unit bed use under capacity, prevented nearly all deaths and eliminated the epidemic. Extending school closures had minimal effects but did reduce transmission in schools; however, extending closures of workplaces and mixed-age venues markedly reduced attack rates and usually or always eliminated the epidemic under any scenario. INTERPRETATION: Controlling SARS-CoV-2 transmission will depend on enhancing and maintaining interventions at both the community and individual levels. Without such interventions, a resurgent epidemic will occur, with the risk of overwhelming our health care systems.
Authors: Anna W Callaghan; Anna N Chard; Patricia Arnold; Cody Loveland; Noah Hull; Mona Saraiya; Sharon Saydah; Wendy Dumont; Laura G Frakes; Daniel Johnson; ReaAnna Peltier; Clayton Van Houten; A Angelica Trujillo; Jazmyn Moore; Dale A Rose; Margaret A Honein; David Carrington; Alexia Harrist; Susan L Hills Journal: MMWR Morb Mortal Wkly Rep Date: 2020-07-03 Impact factor: 17.586
Authors: Wycliffe E Wei; Zongbin Li; Calvin J Chiew; Sarah E Yong; Matthias P Toh; Vernon J Lee Journal: MMWR Morb Mortal Wkly Rep Date: 2020-04-10 Impact factor: 17.586
Authors: Biao Tang; Francesca Scarabel; Nicola Luigi Bragazzi; Zachary McCarthy; Michael Glazer; Yanyu Xiao; Jane M Heffernan; Ali Asgary; Nicholas Hume Ogden; Jianhong Wu Journal: Biology (Basel) Date: 2020-05-16
Authors: Shari Krishnaratne; Lisa M Pfadenhauer; Michaela Coenen; Karin Geffert; Caroline Jung-Sievers; Carmen Klinger; Suzie Kratzer; Hannah Littlecott; Ani Movsisyan; Julia E Rabe; Eva Rehfuess; Kerstin Sell; Brigitte Strahwald; Jan M Stratil; Stephan Voss; Katharina Wabnitz; Jacob Burns Journal: Cochrane Database Syst Rev Date: 2020-12-17
Authors: Pei Yuan; Juan Li; Elena Aruffo; Evgenia Gatov; Qi Li; Tingting Zheng; Nicholas H Ogden; Beate Sander; Jane Heffernan; Sarah Collier; Yi Tan; Jun Li; Julien Arino; Jacques Bélair; James Watmough; Jude Dzevela Kong; Iain Moyles; Huaiping Zhu Journal: CMAJ Open Date: 2022-04-19